ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
10.53
+0.28 (2.73%)
Jun 26, 2026, 4:00 PM EDT - Market closed
ProMIS Neurosciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ProMIS Neurosciences stock have an average target of 31, with a low estimate of 18 and a high estimate of 40. The average target predicts an increase of 194.40% from the current stock price of 10.53.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ProMIS Neurosciences stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 | Buy | Reiterates | $18 | +70.94% | Jun 24, 2026 |
Unknown Analyst Brookline Capital Markets No rating | Brookline Capital Markets | Buy Initiates $40 | Buy | Initiates | $40 | +279.87% | May 20, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $35 | Buy | Reiterates | $35 | +232.38% | May 19, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $35 | Buy | Maintains | $35 | +232.38% | May 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.